Publications
Manasanch EE, Berrios D, Fountain E, et al. Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies. Br J Haematol. 2021.
Davila-Gonzalez D, Barrios-Ruiz A, Fountain E, et al. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center. Clin Lymphoma Myeloma Leuk. 2020. Nov 5; S2152-2650.
Fountain E, Bassett RL, Cain S, Posada L, Gombos DS, Hwu P, Bedikian A, Patel SP. Adjuvant Ipilimumab in High-Risk Uveal Melanoma. (Accepted for Publication – Cancers, 12/2018)
Fountain E, Mistry H, Jain P, Duvic M, Fowler N. Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides. Leuk Lymphoma. 2018 Oct 10:1-4
Fountain EM, Arepally GM. Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis. 2017 May;43(4):429-436.
Fountain EM, Moses MC, Park LP, Woods CW, Arepally GM. Thrombocytopenia in hospitalized medical patients with severe clostridium difficile infection. J Thromb Thrombolysis. 2017 Jan;43(1):38-42.
Abril MK, Barnett AS, Wegermann K, Fountain E, Strand A, Heyman BM, et al. Diagnosis of Capnocytophaga canimorsus sepsis by whole-genome next-generation sequencing. Open Forum Infect Dis. 2016 Jul 12;3(3):ofw144.
Fountain EM, Dhurandhar A. Neuro-Behcet’s Disease: An Unusual Cause of Headache. J Gen Intern Med. 2014 Jun 29;6:956-60.
Bakajin O., Fountain E, Morton K, et al. Materials Aspects in Micro- and Nanofluidic Systems Applied to Biology. MRS Bulletin 31, Special Issue on Materials for Micro and Nanofluidics. 2006. 108-113.